Karaahmet, Fatih

Profile Picture
Name Variants
K., Fatih
F., Karaahmet
K.,Fatih
Karaahmet,F.
F.,Karaahmet
Karaahmet, F.
Karaahmet F.
Karaahmet, Fatih
Fatih, Karaahmet
Job Title
Doçent Doktor
Email Address
fatih.karaahmet@atilim.edu.tr
Main Affiliation
Medical Sciences
Status
Website
ORCID ID
Scopus Author ID
15053210400
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
Scholarly Output

1

Articles

1

Citation Count

2

Supervised Theses

0

Filters

20231
Reset filters

Settings

Scholarly Output Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Article
    Citation - WoS: 2
    Citation - Scopus: 2
    Endoscopic Retrograde Cholangiopancreatography-Oriented Surgery for Accomplished Treatment of Mirizzi Syndrome: a Single-Center Experience
    (Lippincott Williams & Wilkins, 2023) Karaahmet, Fatih; Kekilli, Murat
    BackgroundMirizzi syndrome is a gallstone disease characterized by compression of extrahepatic biliary duct with an impacted stone. Our aim is to identify and describe the incidence, clinical presentation, operative details and the association postoperative complication of Mirizzi syndrome in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). MethodsThe ERCP procedures were held in Gastroenterology Endoscopy Unit and retrospectively evaluated. The patients were divided into two groups, the cholelithiasis + common bile duct (CBD) stone group and the Mirizzi syndrome group. These groups were compared with the demographic characteristics, ERCP procedures, types of Mirizzi syndrome and surgical technique. ResultsA total of 1018 consecutive patients who underwent ERCP were scanned retrospectively. Of the 515 patients fulfilling the criteria for ERCP, 12 had Mirizzi syndrome and 503 had cholelithiasis and CBD stones. Half of the Mirizzi syndrome patients were diagnosed with pre-ERCP ultrasonography. The mean diameter of choledoc was found to be 10 mm in ERCP. ERCP-related complication rates (pancreatitis, bleeding and perforation) were the same in the two groups; 66.6% of the Mirizzi syndrome patients applied cholecystectomy and placement of T-tube surgical procedures, and there were no postoperative complications. ConclusionSurgery is the definitive treatment of Mirizzi syndrome. Thus patients should have a correct preoperative diagnosis for an appropriate and safe surgery. We think that ERCP could be the best guide for this. Also, we believe that intraoperative cholangiography with ERCP and hybrid procedures for guiding surgical treatment may become an advanced treatment option in the future.